FDA · 药品动态·· 11 小时前精选AI 评分60
FDA批准再生元LIVSAYIS
FDA Approval for LIVSAYIS issued to REGENERON PHARMACEUTICALS - Quantisnow
AI 导读
FDA向再生元(REGENERON PHARMACEUTICALS)签发LIVSAYIS的批准。材料仅提供标题与摘要,未披露适应症、剂型及审批依据等细节。
来源:FDA · 药品动态 · news.google.com
FDA Approval for LIVSAYIS issued to REGENERON PHARMACEUTICALS - Quantisnow
FDA向再生元(REGENERON PHARMACEUTICALS)签发LIVSAYIS的批准。材料仅提供标题与摘要,未披露适应症、剂型及审批依据等细节。
来源:FDA · 药品动态 · news.google.com